Press Releases

• Alamar Biosciences: Launches NULISAseq Neuro 220 Panel, Its Largest Precision Proteomics Panel With the Sensitivity and Specificity to Advance Neurological Disease Research More
• Personalis: Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption More
• PerturbAI: Launches From Stealth, Unveils the World’s Largest In Vivo CRISPR Atlas More More*

Financial News

• AN2 Therapeutics: Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights More
• CytomX Therapeutics: Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants More
• Imperative Care: $100 Million Financing More
• More on R1 Therapeutics Emerging With $77.5M, New Way to Tackle Phosphate Control in CKD More* More* More More
• RenovoRx: $10 Million at Market Private Placement More
• XOMA Royalty: 2025 Financial Results and Highlights Recent Business Achievements More
  

Media/Misc Coverage

• CIRM-Funded Clinical Trial Gives Siblings a Second Chance at Life More
  
• More on Xaira Exec Divulging R&D Focus, How $1B Fundraise Fuels AI-Driven Hunt for What the ‘Industry Is Hungriest For’ More More*
  
• Subscribe to LifeSci Startup for Updates on US Startups More

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• Flagship Startup Loses CEO to Ipsen; Ionis to Shed Nearly Six Decades of Board Experience More*
  
• From Seed to Series C: What Investors Look for Beyond the Science More
• Hiring Outlook: February Brings First YOY Job Increase Since 2022 More
• ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
• 10 Companies Hiring in San Francisco and South San Francisco More
• The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More

• PAP – Patient Assistance & Access Programs March 17-18
• Rare Disease Summit March 17-19
• Hub and Specialty Pharmacy Models East March 17-19
• Charles River QC Micro Summit March 17-19
• New Jersey Inaugural Symposium for Life Science Innovation and Development March 23
• Life Sciences Accounting & Reporting Congress 2026 March 23-25
• Patients as Partners in Clinical Research March 24-26
• CMO Summit 360° April 13-14
• Drug Discovery Chemistry April 13-16
• Capital Connect: From Seed to Series A in Today’s Market April 23
  
• Delaware’s DNA | 2026 Life Science Conference April 30
• 2026 Battle of the Bio\Tech Bands West  May 7
  
• Bio-IT World Conference & Expo May 19-21

Companies

SF Bay Sponsors